Increased plasma adrenomedullin in women with recurrent pregnancy loss

Obstet Gynecol. 2003 Aug;102(2):319-24. doi: 10.1016/s0029-7844(03)00481-2.

Abstract

Objective: To evaluate vascular changes and uterine perfusion in women with recurrent pregnancy loss.

Methods: We measured plasma levels of adrenomedullin of 100 pregnant women in the midluteal phase of a nonpregnant cycle (control group: n = 62; recurrent pregnancy loss group: n = 38). We measured the pulsatility index (PI) in the uterine arteries by transvaginal pulsed Doppler ultrasonography at the same time.

Results: The plasma level of adrenomedullin in women with recurrent pregnancy loss (5.6 +/- 1.9, mean +/- standard deviation) was significantly higher (P >.001) than that in control women (3.6 +/- 1.7). Uterine arterial PI of women with recurrent pregnancy loss (2.70 +/- 0.47) was significantly higher (P >.001) than that in control women (2.09 +/- 0.39). Plasma level of adrenomedullin had a significant positive correlation with uterine arterial PI both in the control group (r =.58, P <.001) and in the recurrent pregnancy loss group (r =.78, P <.001). Both plasma adrenomedullin concentration (7.2 +/- 2.3) and uterine arterial PI (3.06 +/- 0.36) were significantly high in women with antiphospholipid antibodies.

Conclusion: Plasma adrenomedullin may serve as a useful biochemical marker for recurrent pregnancy loss caused by impaired uterine perfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Habitual / blood*
  • Abortion, Habitual / physiopathology
  • Adrenomedullin
  • Adult
  • Antibodies, Antiphospholipid / analysis
  • Endometrium / pathology
  • Female
  • Humans
  • Luteal Phase / physiology
  • Peptides / blood*
  • Prospective Studies
  • Ultrasonography, Doppler, Pulsed
  • Uterus / blood supply

Substances

  • Antibodies, Antiphospholipid
  • Peptides
  • Adrenomedullin